Histological and Behavioral Protection by (−)-Nicotine against Quinolinic Acid-Induced Neurodegeneration in the Hippocampus

This publication has 26 references indexed in Scilit:

• In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
  Brain Research, 1996
• The Pharmacology of (-)-Nicotine and Novel Cholinergic Channel Modulators
  Published by Elsevier ,1996
• Nicotine treatment counteracts perinatal asphyxia-induced changes in the mesostriatal/limbic dopamine systems and in motor behaviour in the four-week-old male rat
  Neuroscience, 1995
• Nicotine-induced protection of cultured cortical neurons againstN-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
  Brain Research, 1994
• A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate
  Brain, 1993
• Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats
  Neuroscience Letters, 1993
• Muscimol injections in the medial septum impair spatial learning
  Brain Research, 1990
• Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation
  Journal of Neuroscience, 1988
• Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
  Brain Research, 1988
• Effects of altered cholinergic function on working and reference memory in the rat
  Canadian Journal of Physiology and Pharmacology, 1986